_id
69130dffccc777a4e85d7d93
Ticker
LFTSF
Name
LifeTech Scientific Corporation
Exchange
PINK
Address
LifeTech Scientific Building, Shenzhen, China, 518063
Country
USA
Sector
Healthcare
Industry
Medical Devices
Currency
USD
Website
https://www.lifetechmed.com
Description
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company's products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers. It also involved in the biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.
Last Close
0.2335
Volume
-
Current Price
0.2335
Change
0
Last Updated
2026-01-04T16:28:01.968Z
Image
-
Ipo Date
-
Market Cap
1027579200
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.996
Sentiment Sources
1
Current Quarter
2025-06-30
Revenue
676707000
Cost Of Revenue
178952000
Gross Profit
497755000
Operating Expenses
433368000
Operating Income
64387000
Interest Expense
-
Pretax Income
79800000
Net Income
55074000
Eps
0.01265880392989734
Dividends Per Share
-
Shares Outstanding
4400767400
Income Tax Expense
38035000
EBITDA
70827000
Operating Margin
9.514753061517023
Total Other Income Expense Net
15413000
Cash
782609000
Short Term Investments
612367000
Receivables
246322000
Inventories
493559000
Total Current Assets
2573290000
Property Plant Equipment
995206000
Total Assets
5333685000
Payables
841265000
Short Term Debt
3059000
Long Term Debt
-
Total Liabilities
1596735000
Equity
3770199000
Bs_currency_symbol
CNY
Depreciation
42750000
Change In Working Capital
-
Cash From Operations
391273000
Capital Expenditures
21762000
Cash From Investing
-273025000
Cash From Financing
-780000
Net Change In Cash
782609000
Cf_currency_symbol
-
PE
23.35
PB
0.269448988766906
ROE
1.4607716993187894
ROA
1.0325694149542013
FCF
369511000
Fcf Percent
0.5460428220780928
Piotroski FScore
4
Health Score
71
Deep Value Investing Score
9
Defensive Investing Score
7
Dividend Investing Score
3
Economic Moat Investing Score
7.3
Garp Investing Score
6.5
Growth Investing Score
5
Momentum Investing Score
6.5
Net Net Investing Score
6
Quality Investing Score
6.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
676707000
Quarters > 0 > income Statement > cost Of Revenue
178952000
Quarters > 0 > income Statement > gross Profit
497755000
Quarters > 0 > income Statement > operating Expenses
433368000
Quarters > 0 > income Statement > operating Income
64387000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
79800000
Quarters > 0 > income Statement > net Income
55074000
Quarters > 0 > income Statement > eps
0.01265880392989734
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
4350648000
Quarters > 0 > income Statement > income Tax Expense
38035000
Quarters > 0 > income Statement > EBITDA
70827000
Quarters > 0 > income Statement > operating Margin
9.514753061517023
Quarters > 0 > income Statement > total Other Income Expense Net
15413000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
782609000
Quarters > 0 > balance Sheet > short Term Investments
612367000
Quarters > 0 > balance Sheet > receivables
246322000
Quarters > 0 > balance Sheet > inventories
493559000
Quarters > 0 > balance Sheet > total Current Assets
2573290000
Quarters > 0 > balance Sheet > property Plant Equipment
995206000
Quarters > 0 > balance Sheet > total Assets
5333685000
Quarters > 0 > balance Sheet > payables
841265000
Quarters > 0 > balance Sheet > short Term Debt
3059000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1596735000
Quarters > 0 > balance Sheet > equity
3770199000
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
55074000
Quarters > 0 > cash Flow > depreciation
42750000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
391273000
Quarters > 0 > cash Flow > capital Expenditures
21762000
Quarters > 0 > cash Flow > cash From Investing
-273025000
Quarters > 0 > cash Flow > cash From Financing
-780000
Quarters > 0 > cash Flow > net Change In Cash
782609000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
0.01265880392989734
Quarters > 0 > ratios > PB
0.269448988766906
Quarters > 0 > ratios > ROE
1.4607716993187894
Quarters > 0 > ratios > ROA
1.0325694149542013
Quarters > 0 > ratios > FCF
369511000
Quarters > 0 > ratios > Piotroski FScore
4
Quarters > 0 > ratios > fcf Percent
0.5460428220780928
Quarters > 0 > health Score
71
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
650868000
Quarters > 1 > income Statement > cost Of Revenue
184817000
Quarters > 1 > income Statement > gross Profit
466051000
Quarters > 1 > income Statement > operating Expenses
481721000
Quarters > 1 > income Statement > operating Income
-15670000
Quarters > 1 > income Statement > interest Expense
1890000
Quarters > 1 > income Statement > pretax Income
-9650000
Quarters > 1 > income Statement > net Income
16831000
Quarters > 1 > income Statement > eps
0.003830026121365247
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
4394487000
Quarters > 1 > income Statement > income Tax Expense
7667000
Quarters > 1 > income Statement > EBITDA
80403000
Quarters > 1 > income Statement > operating Margin
-2.407554219903268
Quarters > 1 > income Statement > total Other Income Expense Net
6020000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
665755000
Quarters > 1 > balance Sheet > short Term Investments
516133000
Quarters > 1 > balance Sheet > receivables
155513000
Quarters > 1 > balance Sheet > inventories
532398000
Quarters > 1 > balance Sheet > total Current Assets
2334173000
Quarters > 1 > balance Sheet > property Plant Equipment
1003468000
Quarters > 1 > balance Sheet > total Assets
4900378000
Quarters > 1 > balance Sheet > payables
59543000
Quarters > 1 > balance Sheet > short Term Debt
3787000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1424949000
Quarters > 1 > balance Sheet > equity
3494507000
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
-6562000
Quarters > 1 > cash Flow > depreciation
46220000
Quarters > 1 > cash Flow > change In Working Capital
-33274000
Quarters > 1 > cash Flow > cash From Operations
218790000
Quarters > 1 > cash Flow > capital Expenditures
101832000
Quarters > 1 > cash Flow > cash From Investing
-293205000
Quarters > 1 > cash Flow > cash From Financing
-92061000
Quarters > 1 > cash Flow > net Change In Cash
739122500
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
0.003830026121365247
Quarters > 1 > ratios > PB
0.2936359018596901
Quarters > 1 > ratios > ROE
0.48164161639968095
Quarters > 1 > ratios > ROA
0.34346330017806787
Quarters > 1 > ratios > FCF
116958000
Quarters > 1 > ratios > Piotroski FScore
4
Quarters > 1 > ratios > fcf Percent
0.17969542211323955
Quarters > 1 > health Score
67
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
652831000
Quarters > 2 > income Statement > cost Of Revenue
137447000
Quarters > 2 > income Statement > gross Profit
515384000
Quarters > 2 > income Statement > operating Expenses
313378000
Quarters > 2 > income Statement > operating Income
202006000
Quarters > 2 > income Statement > interest Expense
554945
Quarters > 2 > income Statement > pretax Income
208645000
Quarters > 2 > income Statement > net Income
205557000
Quarters > 2 > income Statement > eps
0.04617015283810427
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
4452162000
Quarters > 2 > income Statement > income Tax Expense
22837000
Quarters > 2 > income Statement > EBITDA
208478000
Quarters > 2 > income Statement > operating Margin
30.943077151667126
Quarters > 2 > income Statement > total Other Income Expense Net
6639000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
832577000
Quarters > 2 > balance Sheet > short Term Investments
208912000
Quarters > 2 > balance Sheet > receivables
122173000
Quarters > 2 > balance Sheet > inventories
549561000
Quarters > 2 > balance Sheet > total Current Assets
2218617000
Quarters > 2 > balance Sheet > property Plant Equipment
1010531000
Quarters > 2 > balance Sheet > total Assets
4819565000
Quarters > 2 > balance Sheet > payables
452635000
Quarters > 2 > balance Sheet > short Term Debt
102534000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1429289000
Quarters > 2 > balance Sheet > equity
3422460000
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
205557000
Quarters > 2 > cash Flow > depreciation
41776000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
102670000
Quarters > 2 > cash Flow > capital Expenditures
181169000
Quarters > 2 > cash Flow > cash From Investing
-224330000
Quarters > 2 > cash Flow > cash From Financing
-24906000
Quarters > 2 > cash Flow > net Change In Cash
-73367500
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
0.04617015283810427
Quarters > 2 > ratios > PB
0.30375222120930556
Quarters > 2 > ratios > ROE
6.0061184060588
Quarters > 2 > ratios > ROA
4.26505296639842
Quarters > 2 > ratios > FCF
-78499000
Quarters > 2 > ratios > Piotroski FScore
3
Quarters > 2 > ratios > fcf Percent
-0.1202439835118124
Quarters > 2 > health Score
58
Quarters > 3 > quarter
2024-03-31
Quarters > 3 > income Statement > revenue
326415500
Quarters > 3 > income Statement > cost Of Revenue
68723500
Quarters > 3 > income Statement > gross Profit
257692000
Quarters > 3 > income Statement > operating Expenses
156689000
Quarters > 3 > income Statement > operating Income
101003000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
104322500
Quarters > 3 > income Statement > net Income
102778500
Quarters > 3 > income Statement > eps
0.023085076419052136
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
4452162000
Quarters > 3 > income Statement > income Tax Expense
11418500
Quarters > 3 > income Statement > EBITDA
104239000
Quarters > 3 > income Statement > operating Margin
30.943077151667126
Quarters > 3 > income Statement > total Other Income Expense Net
3319500
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
832577000
Quarters > 3 > balance Sheet > short Term Investments
60912000
Quarters > 3 > balance Sheet > receivables
122173000
Quarters > 3 > balance Sheet > inventories
549561000
Quarters > 3 > balance Sheet > total Current Assets
2218617000
Quarters > 3 > balance Sheet > property Plant Equipment
983607000
Quarters > 3 > balance Sheet > total Assets
4819565000
Quarters > 3 > balance Sheet > payables
452635000
Quarters > 3 > balance Sheet > short Term Debt
102534000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
1429288999
Quarters > 3 > balance Sheet > equity
3422460000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
102778500
Quarters > 3 > cash Flow > depreciation
20888000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
51335000
Quarters > 3 > cash Flow > capital Expenditures
90584500
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-12453000
Quarters > 3 > cash Flow > net Change In Cash
-73367500
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
0.023085076419052136
Quarters > 3 > ratios > PB
0.30375222120930556
Quarters > 3 > ratios > ROE
3.0030592030294
Quarters > 3 > ratios > ROA
2.13252648319921
Quarters > 3 > ratios > FCF
-39249500
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
-0.1202439835118124
Quarters > 3 > health Score
54
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
1303699000
Annuals > 0 > income Statement > cost Of Revenue
322264000
Annuals > 0 > income Statement > gross Profit
981435000
Annuals > 0 > income Statement > operating Expenses
795099000
Annuals > 0 > income Statement > operating Income
186336000
Annuals > 0 > income Statement > interest Expense
1890000
Annuals > 0 > income Statement > pretax Income
198995000
Annuals > 0 > income Statement > net Income
222388000
Annuals > 0 > income Statement > eps
0.050606134458925464
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
4394487000
Annuals > 0 > income Statement > income Tax Expense
30504000
Annuals > 0 > income Statement > EBITDA
288881000
Annuals > 0 > income Statement > operating Margin
14.292869749842563
Annuals > 0 > income Statement > total Other Income Expense Net
12659000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
665755000
Annuals > 0 > balance Sheet > short Term Investments
516133000
Annuals > 0 > balance Sheet > receivables
155513000
Annuals > 0 > balance Sheet > inventories
532398000
Annuals > 0 > balance Sheet > total Current Assets
2334173000
Annuals > 0 > balance Sheet > property Plant Equipment
1003468000
Annuals > 0 > balance Sheet > total Assets
4900378000
Annuals > 0 > balance Sheet > payables
59543000
Annuals > 0 > balance Sheet > short Term Debt
3787000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1424949000
Annuals > 0 > balance Sheet > equity
3494507000
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
198995000
Annuals > 0 > cash Flow > depreciation
87996000
Annuals > 0 > cash Flow > change In Working Capital
-33274000
Annuals > 0 > cash Flow > cash From Operations
321460000
Annuals > 0 > cash Flow > capital Expenditures
283001000
Annuals > 0 > cash Flow > cash From Investing
-517535000
Annuals > 0 > cash Flow > cash From Financing
-116967000
Annuals > 0 > cash Flow > net Change In Cash
-313557000
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
0.050606134458925464
Annuals > 0 > ratios > PB
0.2936359018596901
Annuals > 0 > ratios > ROE
6.363930591639965
Annuals > 0 > ratios > ROA
4.538180524033044
Annuals > 0 > ratios > FCF
38459000
Annuals > 0 > ratios > Piotroski FScore
4
Annuals > 0 > ratios > fcf Percent
0.029499907570689248
Annuals > 0 > health Score
61
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1267175000
Annuals > 1 > income Statement > cost Of Revenue
271538000
Annuals > 1 > income Statement > gross Profit
995637000
Annuals > 1 > income Statement > operating Expenses
612359000
Annuals > 1 > income Statement > operating Income
383278000
Annuals > 1 > income Statement > interest Expense
722000
Annuals > 1 > income Statement > pretax Income
175581000
Annuals > 1 > income Statement > net Income
263242000
Annuals > 1 > income Statement > eps
0.059207115595819364
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
4446121000
Annuals > 1 > income Statement > income Tax Expense
68091000
Annuals > 1 > income Statement > EBITDA
253462000
Annuals > 1 > income Statement > operating Margin
30.24665101505317
Annuals > 1 > income Statement > total Other Income Expense Net
-207697000
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
979312000
Annuals > 1 > balance Sheet > short Term Investments
200000000
Annuals > 1 > balance Sheet > receivables
105185000
Annuals > 1 > balance Sheet > inventories
483605000
Annuals > 1 > balance Sheet > total Current Assets
2231143000
Annuals > 1 > balance Sheet > property Plant Equipment
921462000
Annuals > 1 > balance Sheet > total Assets
4696364000
Annuals > 1 > balance Sheet > payables
124086000
Annuals > 1 > balance Sheet > short Term Debt
6293000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
1372394000
Annuals > 1 > balance Sheet > equity
3370242000
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
175581000
Annuals > 1 > cash Flow > depreciation
77159000
Annuals > 1 > cash Flow > change In Working Capital
-27286000
Annuals > 1 > cash Flow > cash From Operations
418049000
Annuals > 1 > cash Flow > capital Expenditures
292687000
Annuals > 1 > cash Flow > cash From Investing
-453882000
Annuals > 1 > cash Flow > cash From Financing
182709000
Annuals > 1 > cash Flow > net Change In Cash
145520000
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
0.059207115595819364
Annuals > 1 > ratios > PB
0.3080399726488484
Annuals > 1 > ratios > ROE
7.810774419166338
Annuals > 1 > ratios > ROA
5.605229918294238
Annuals > 1 > ratios > FCF
125362000
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.09893029770947186
Annuals > 1 > health Score
70
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1097310000
Annuals > 2 > income Statement > cost Of Revenue
223382000
Annuals > 2 > income Statement > gross Profit
873928000
Annuals > 2 > income Statement > operating Expenses
497994000
Annuals > 2 > income Statement > operating Income
375934000
Annuals > 2 > income Statement > interest Expense
632000
Annuals > 2 > income Statement > pretax Income
378046000
Annuals > 2 > income Statement > net Income
325337000
Annuals > 2 > income Statement > eps
0.07384925841349974
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
4405420000
Annuals > 2 > income Statement > income Tax Expense
59307000
Annuals > 2 > income Statement > EBITDA
445784000
Annuals > 2 > income Statement > operating Margin
34.25959847262852
Annuals > 2 > income Statement > total Other Income Expense Net
2112000
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
833792000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
137090000
Annuals > 2 > balance Sheet > inventories
241406000
Annuals > 2 > balance Sheet > total Current Assets
1396658000
Annuals > 2 > balance Sheet > property Plant Equipment
816033000
Annuals > 2 > balance Sheet > total Assets
3690103000
Annuals > 2 > balance Sheet > payables
62648000
Annuals > 2 > balance Sheet > short Term Debt
5037000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
769046000
Annuals > 2 > balance Sheet > equity
2900445000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
378046000
Annuals > 2 > cash Flow > depreciation
67106000
Annuals > 2 > cash Flow > change In Working Capital
-81445000
Annuals > 2 > cash Flow > cash From Operations
388318000
Annuals > 2 > cash Flow > capital Expenditures
335473000
Annuals > 2 > cash Flow > cash From Investing
-458468000
Annuals > 2 > cash Flow > cash From Financing
-215201000
Annuals > 2 > cash Flow > net Change In Cash
-285472000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.07384925841349974
Annuals > 2 > ratios > PB
0.3546578438825767
Annuals > 2 > ratios > ROE
11.21679604336576
Annuals > 2 > ratios > ROA
8.816474770487437
Annuals > 2 > ratios > FCF
52845000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.04815867895125352
Annuals > 2 > health Score
70
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
925334000
Annuals > 3 > income Statement > cost Of Revenue
177800000
Annuals > 3 > income Statement > gross Profit
747534000
Annuals > 3 > income Statement > operating Expenses
420864000
Annuals > 3 > income Statement > operating Income
328739000
Annuals > 3 > income Statement > interest Expense
2609000
Annuals > 3 > income Statement > pretax Income
332928000
Annuals > 3 > income Statement > net Income
292472000
Annuals > 3 > income Statement > eps
0.06409794489985737
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
4562892000
Annuals > 3 > income Statement > income Tax Expense
49571000
Annuals > 3 > income Statement > EBITDA
397588000
Annuals > 3 > income Statement > operating Margin
35.52652339587652
Annuals > 3 > income Statement > total Other Income Expense Net
4189000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1119264000
Annuals > 3 > balance Sheet > short Term Investments
357112000
Annuals > 3 > balance Sheet > receivables
110036000
Annuals > 3 > balance Sheet > inventories
129286000
Annuals > 3 > balance Sheet > total Current Assets
1837072000
Annuals > 3 > balance Sheet > property Plant Equipment
743705000
Annuals > 3 > balance Sheet > total Assets
3183715000
Annuals > 3 > balance Sheet > payables
30756000
Annuals > 3 > balance Sheet > short Term Debt
11045000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
653613000
Annuals > 3 > balance Sheet > equity
2503582000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
332928000
Annuals > 3 > cash Flow > depreciation
62051000
Annuals > 3 > cash Flow > change In Working Capital
98633000
Annuals > 3 > cash Flow > cash From Operations
488853000
Annuals > 3 > cash Flow > capital Expenditures
343285000
Annuals > 3 > cash Flow > cash From Investing
-86756000
Annuals > 3 > cash Flow > cash From Financing
-256375000
Annuals > 3 > cash Flow > net Change In Cash
147581000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.06409794489985737
Annuals > 3 > ratios > PB
0.42556436417900434
Annuals > 3 > ratios > ROE
11.682141827190003
Annuals > 3 > ratios > ROA
9.18650067609695
Annuals > 3 > ratios > FCF
145568000
Annuals > 3 > ratios > Piotroski FScore
4
Annuals > 3 > ratios > fcf Percent
0.1573140076988417
Annuals > 3 > health Score
82
Valuation > metrics > PE
23.35
Valuation > metrics > PB
0.269448988766906
Valuation > final Score
100
Valuation > verdict
36.5% Undervalued
Profitability > metrics > ROE
1.4607716993187894
Profitability > metrics > ROA
2.1402173870803525
Profitability > metrics > Net Margin
0.08138529673847027
Profitability > final Score
22
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.4235147799890669
Risk > metrics > Interest Coverage
7.175638025186671
Risk > final Score
89
Risk > verdict
Low
Liquidity > metrics > Current Ratio
3.0477518109161887
Liquidity > metrics > Quick Ratio
2.463190670879899
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
7
Prev Profitabilities > 1
70
Prev Profitabilities > 2
50
Prev Risks > 0
27
Prev Risks > 1
100
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:08:07.284Z
LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company's products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers. It also involved in the biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of LifeTech Scientific Corporation
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.